Big Pharma's Profits vs. Public Health: The Sackler Family's Role in the Opioid Crisis
The opioid epidemic is a national tragedy, and the Sacklers' greed is a part of it. The fact that they took out billions while people were dying is unacceptable.
Picture this: while communities across Pennsylvania are grappling with one of the highest opioid overdose death rates in the country, the Sackler family was quietly extracting billions from Purdue Pharma, the makers of OxyContin. This episode of the 'Battling Opioids' podcast takes a hard look at how corporate greed exacerbated an already devastating crisis. The Sacklers' actions, especially after Purdue was fined for misleading marketing practices, highlight a troubling disconnect between profit motives and public health.
But it's not all doom and gloom. The episode also shines a light on Geisinger, a healthcare system making strides in the fight against opioid addiction. Over the past three years, Geisinger has slashed opioid prescriptions by 40% and established four medication-assisted treatment centers across Pennsylvania. These efforts underscore the importance of prevention and treatment in tackling addiction.
Additionally, the role of public media in raising awareness and fostering community connections is emphasized, showing how collective efforts can make a significant impact. If you're affected by the opioid crisis or know someone who is, this episode offers a blend of hard truths and hopeful solutions.